相关实验视频
Updated: Sep 10, 2025

07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.2K
由ERG驱动的前列腺癌的发病依赖于细胞环境,需要KMT2A和DOT1L
Weiran Feng1,2,3, Erik Ladewig4, Matthew Lange5
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. weiran.feng@fccc.edu.
Nature genetics
|August 26, 2025
概括
在前列腺癌中激活瘤发起的基底细胞,驱动中间细胞增殖. 这些细胞转化为光细胞, 它们的存在表明人类癌症的预后更差.
科学领域:
- 前列腺癌研究
- 癌细胞生物学
- 分子瘤学
背景情况:
- 在前列腺癌中,ERG转录因子转位很常见,但其瘤发生机制尚不清楚.
- 了解ERG的作用对于开发向疗法至关重要.
- 确定ERG驱动的前列腺癌中涉及的特定细胞类型至关重要.
研究的目的:
- 阐明ERG驱动的前列腺癌瘤发生机制.
- 确定负责发起ERG阳性前列腺瘤的特定细胞群.
- 研究中介细胞在ERG驱动的前列腺癌进展中的作用.
主要方法:
- 在小鼠模型中追踪血统以追踪细胞群.
- 对ERG阳性人类前列腺癌的转录组分析.
- 单细胞分析以确定细胞状态和分子特征.
- 在体内的瘤性测试.
主要成果:
- 瘤启动ERG活动存在于罕见的基底细胞,而不是光细胞.
- ERG激活诱导基底细胞形成增殖中间细胞 (IM),然后转化为光细胞.
- 人前列腺癌中的ERG+IM细胞与预后较差,并表现出特定的染色质状态和基因表达模式 (STAT3,KMT2A/MLL1,DOT1L).
结论:
- 通过特定的基底细胞谱系驱动前列腺瘤发生,从而获得光质特征.
- 中间细胞是ERG驱动前列腺癌进展的关键参与者,并与不良结果相关.
- 在ERG+IM细胞中准特定的分子通路 (STAT3,KMT2A/MLL1,DOT1L) 是潜在的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

